[{"source": "benzinga", "link": "https://www.benzinga.com/government/22/03/25975611/astonishing-and-completely-nontransparent-former-sec-commisioner-talks-regulation-with-jon-stewart", "title": "'Astonishing And Completely Nontransparent': Former SEC Commisioner Talks Regulation With Jon Stewart", "date": "2022-03-03 17:18", "summary": "About a year after retail traders\u00a0turned the tables on institutional investors, targeting outsized short positions that sent GameStop Corp (NYSE: GME)\u00a0shares soaring,\u00a0former SEC commissioner Robert Jackson spoke about the underlying problem with Jon Stewart.&amp;nbs", "tickers": ["AAPL", "GME"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"'Astonishing And Completely Nontransparent': Former SEC Commisioner Talks Regulation With Jon Stewart. About a year after retail traders\u00a0turned the tables on institutional investors, targeting outsized short positions that sent GameStop Corp (NYSE: GME)\u00a0shares soaring,\u00a0former SEC commissioner Robert Jackson spoke about the underlying problem with Jon Stewart.&amp;nbs\"\n\nStock Prediction(s) for AAPL, GME:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because they are not involved in the issue of short selling.\n- GameStop Corp (NYSE: GME) will increase because they were the victim of short selling, and the issue is being talked about more openly."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25971483/10-things-that-are-surprisingly-cheaper-than-a-barrel-of-crude-oil-right-now", "title": "10 Things That Are Surprisingly Cheaper Than A Barrel Of Crude Oil Right Now", "date": "2022-03-03 16:32", "summary": "Oil prices continue to rise, spiking through $112 on Wednesday as a result of the Russian invasion of Ukraine.\u00a0\n\nFor a little context, the last time black gold was this expensive was 2014.\u00a0\n\nPicture yourself in 2014. Do you remember the following?", "tickers": ["AAPL", "AMZN", "CROX", "HOOD", "NFLX"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"10 Things That Are Surprisingly Cheaper Than A Barrel Of Crude Oil Right Now. Oil prices continue to rise, spiking through $112 on Wednesday as a result of the Russian invasion of Ukraine.\u00a0\n\nFor a little context, the last time black gold was this expensive was 2014.\u00a0\n\nPicture yourself in 2014. Do you remember the following?\"\n\nStock Prediction(s) for AAPL, AMZN, CROX, HOOD, NFLX:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because they have a lot of money and they are working on a new product.\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they have a lot of money and they are working on a new product.\n- Crocs, Inc. (NASDAQ: CROX) will increase because they have a lot of money and they are working on a new product.\n- HOODCO, Inc. (OTC: HOOD) will increase because they have a lot of money and they are working on a new product"}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/25966103/apple-analyst-russian-sales-ban-signals-industrywide-trend", "title": "Apple Analyst: Russian Sales Ban Signals Industrywide Trend", "date": "2022-03-03 14:12", "summary": "Apple, Inc.", "tickers": ["AAPL"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Apple Analyst: Russian Sales Ban Signals Industrywide Trend. Apple, Inc.\"\n\nStock Prediction(s) for AAPL:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because the Russian sales ban signals a industrywide trend.\n- Apple Inc. (NASDAQ: AAPL) will decrease because the Russian sales ban signals a industrywide trend."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/technicals/22/03/25969692/a-bullish-sign-for-apple-meta-platforms-and-paypal-stocks-what-the-charts-are-saying", "title": "A Bullish Sign For Apple, Meta Platforms And PayPal Stocks: What The Charts Are Saying", "date": "2022-03-03 13:06", "summary": "Apple, Inc (NASDAQ: AAPL), Meta Platforms, Inc (NASDAQ: FB) and PayPal Holdings, Inc (NASDAQ: PYPL) are all trading higher in strong", "tickers": ["AAPL", "FB", "PYPL"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"A Bullish Sign For Apple, Meta Platforms And PayPal Stocks: What The Charts Are Saying. Apple, Inc (NASDAQ: AAPL), Meta Platforms, Inc (NASDAQ: FB) and PayPal Holdings, Inc (NASDAQ: PYPL) are all trading higher in strong\"\n\nStock Prediction(s) for AAPL, FB, PYPL:", "Prediction": "\n- Apple, Inc (NASDAQ: AAPL) will continue to increase because their products are in high demand and they have a strong future.\n- Meta Platforms, Inc (NASDAQ: FB) will continue to increase because they are a strong competitor to Apple and they have a good future.\n- PayPal Holdings, Inc (NASDAQ: PYPL) will continue to increase because they are a strong competitor to Apple and they have a good future."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25964229/5-things-you-might-not-know-about-volodymyr-zelensky-president-of-ukraine", "title": "5 Things You Might Not Know About Volodymyr Zelensky, President Of Ukraine", "date": "2022-03-03 17:09", "summary": "The invasion of Ukraine by Russia has brought worldwide attention to\u00a0Ukrainian President Volodymyr Zelensky.\n\nHere are five things you might not know about\u00a0Zelensky.", "tickers": ["DIS", "FB", "TWTR"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"5 Things You Might Not Know About Volodymyr Zelensky, President Of Ukraine. The invasion of Ukraine by Russia has brought worldwide attention to\u00a0Ukrainian President Volodymyr Zelensky.\n\nHere are five things you might not know about\u00a0Zelensky.\"\n\nStock Prediction(s) for DIS, FB, TWTR:", "Prediction": "\n- Disney (NYSE: DIS) will increase because they own ABC, which will give them more coverage of the Ukrainian President.\n- Facebook (NASDAQ: FB) will increase because they own WhatsApp, which will give them more coverage of the Ukrainian President.\n- Twitter (NYSE: TWTR) will increase because they own Periscope, which will give them more coverage of the Ukrainian President."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/25969557/randi-zuckerberg-sings-twisted-sister-crypto-warcry-or-viral-cringe", "title": "Randi Zuckerberg Sings Twisted Sister: Crypto Warcry Or Viral Cringe?", "date": "2022-03-03 14:31", "summary": "NFT and cryptocurrency enthusiast Randi Zuckerberg has gone viral.", "tickers": ["FB", "SHIBUSD", "TWTR"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Randi Zuckerberg Sings Twisted Sister: Crypto Warcry Or Viral Cringe?. NFT and cryptocurrency enthusiast Randi Zuckerberg has gone viral.\"\n\nStock Prediction(s) for FB, SHIBUSD, TWTR:", "Prediction": "\n- Facebook, Inc. (NASDAQ: FB) will increase because Randi Zuckerberg is an influential figure and this could lead to more people getting interested in cryptocurrencies.\n- SHIBUSD will increase because this could lead to more people getting interested in cryptocurrencies.\n- Twitter, Inc. (NYSE: TWTR) will decrease because this could lead to more people getting interested in cryptocurrencies."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/gaming/22/03/25972393/video-game-world-reacts-to-russia-ukraine-conflict-ea-makes-a-move-playstation-and-xbox-silent", "title": "Video Game World Reacts To Russia-Ukraine Conflict: EA Makes A Move, Playstation And Xbox Silent", "date": "2022-03-03 17:27", "summary": "The list of companies ending or suspending business in the country of Russia is growing. One sector that has been relatively silent on making any changes in the video game sector.", "tickers": ["EA", "MSFT", "SONY", "TCEHY", "U", "UBSFY"], "sentiments": [0, 0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Video Game World Reacts To Russia-Ukraine Conflict: EA Makes A Move, Playstation And Xbox Silent. The list of companies ending or suspending business in the country of Russia is growing. One sector that has been relatively silent on making any changes in the video game sector.\"\n\nStock Prediction(s) for EA, MSFT, SONY, TCEHY, U, UBSFY:", "Prediction": "\n- Electronic Arts Inc. (NASDAQ: EA) will decrease because they have pulled out of Russia in light of the conflict.\n- Microsoft Corporation (NASDAQ: MSFT) will decrease because they have pulled out of Russia in light of the conflict.\n- Sony Corporation (NYSE: SONY) will decrease because they have pulled out of Russia in light of the conflict.\n- Tencent Holdings Ltd. (HKG: 0700) will decrease because they have pulled out of Russia in light of the conflict.\n- Ubisoft Entertainment SA (EPA: UBI) will decrease because they have pulled out of Russia in"}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/25966309/looking-at-microsofts-recent-whale-trades", "title": "Looking At Microsoft's Recent Whale Trades", "date": "2022-03-03 10:49", "summary": "Someone with a lot of money to spend has taken a bullish stance on Microsoft (NASDAQ:MSFT).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["MSFT"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Looking At Microsoft's Recent Whale Trades. Someone with a lot of money to spend has taken a bullish stance on Microsoft (NASDAQ:MSFT).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for MSFT:", "Prediction": "\n- Microsoft will continue to increase because a whale has taken a bullish stance on the company.\n- Microsoft will continue to increase because they are a strong company with a bright future."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25959770/insiders-sell-more-than-323m-of-5-stocks", "title": "Insiders Sell More Than $323M Of 5 Stocks", "date": "2022-03-03 07:21", "summary": "Although the IHS Markit Eurozone services PMI was revised lower to 55.5 in February versus a preliminary reading of 55.8, there were a few notable insider trades.", "tickers": ["ANET", "LBRT", "MP", "MSFT", "ZETA"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Insiders Sell More Than $323M Of 5 Stocks. Although the IHS Markit Eurozone services PMI was revised lower to 55.5 in February versus a preliminary reading of 55.8, there were a few notable insider trades.\"\n\nStock Prediction(s) for ANET, LBRT, MP, MSFT, ZETA:", "Prediction": "\n- Arista Networks Inc (NYSE: ANET) will increase because of the positive news of insiders selling.\n- Liberty Broadband Corp (NASDAQ: LBRT) will increase because of the positive news of insiders selling.\n- Mellanox Technologies, Ltd. (NASDAQ: MLNX) will increase because of the positive news of insiders selling.\n- Microsoft Corporation (NASDAQ: MSFT) will increase because of the positive news of insiders selling.\n- Zeta Interactive Corp (ZETA) will increase because of the positive news of insiders selling."}, {"source": "benzinga", "link": "https://www.benzinga.com/fintech/22/03/25955324/quiver-quantitative-closes-2m-round-led-by-allos-ventures", "title": "Quiver Quantitative Closes $2M Round Led By Allos Ventures", "date": "2022-03-03 10:13", "summary": "Quiver Quantitative, an alternative data platform for retail investors, formally announced the closure of a $2 million round led by Allos Ventures.", "tickers": ["TSLA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Quiver Quantitative Closes $2M Round Led By Allos Ventures. Quiver Quantitative, an alternative data platform for retail investors, formally announced the closure of a $2 million round led by Allos Ventures.\"\n\nStock Prediction(s) for TSLA:", "Prediction": "\n- Tesla, Inc. (NASDAQ: TSLA) will increase because they are expanding their business to include alternative data."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25956320/bad-weather-perhaps-elon-musk-takes-a-dig-at-russia-as-country-cries-foul-over-spacex-lending-a-hand", "title": "'Bad Weather Perhaps:' Elon Musk Takes A Dig At Russia As Country Cries Foul Over SpaceX Lending A Hand In Ukraine", "date": "2022-03-03 07:24", "summary": "Tesla Inc\u00a0(NASDAQ:\u00a0TSLA) and\u00a0SpaceX\u00a0CEO\u00a0Elon\u00a0Musk\u00a0on Wednesday took a swipe at Russian space agency chief\u00a0Dmitry\u00a0Rogozin,\u00a0who alleged the billionaire of taking Ukraine&#39;", "tickers": ["TSLA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"'Bad Weather Perhaps:' Elon Musk Takes A Dig At Russia As Country Cries Foul Over SpaceX Lending A Hand In Ukraine. Tesla Inc\u00a0(NASDAQ:\u00a0TSLA) and\u00a0SpaceX\u00a0CEO\u00a0Elon\u00a0Musk\u00a0on Wednesday took a swipe at Russian space agency chief\u00a0Dmitry\u00a0Rogozin,\u00a0who alleged the billionaire of taking Ukraine&#39;\"\n\nStock Prediction(s) for TSLA:", "Prediction": "\n- Tesla Inc (NASDAQ: TSLA) will increase because they are a competitor of SpaceX, and SpaceX is helping out in Ukraine."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/25956981/floki-inu-says-it-will-continue-the-battle-as-uk-strikes-down-ad-gunning-at-dogecoin", "title": "Floki Inu Says It Will Continue The Battle As UK Strikes Down Ad Gunning At Dogecoin", "date": "2022-03-03 06:50", "summary": "Floki Inu (CRYPTO: FLOKI) \u2014 a Dogecoin (CRYPTO: DOGE)-inspired cryptocurrency\u00a0\u2014 has responded to an advertising ban by a United Kingdom\u00a0regulator, saying it will continue to battle for the right to advertise its", "tickers": ["COIN", "DOGEUSD", "TSLA"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Floki Inu Says It Will Continue The Battle As UK Strikes Down Ad Gunning At Dogecoin. Floki Inu (CRYPTO: FLOKI) \u2014 a Dogecoin (CRYPTO: DOGE)-inspired cryptocurrency\u00a0\u2014 has responded to an advertising ban by a United Kingdom\u00a0regulator, saying it will continue to battle for the right to advertise its\"\n\nStock Prediction(s) for COIN, DOGEUSD, TSLA:", "Prediction": "\n- Coin (CRYPTO: COIN) will increase because they are a direct competitor of Floki Inu.\n- Dogecoin (CRYPTO: DOGEUSD) will increase because they are a direct competitor of Floki Inu.\n- Tesla, Inc. (NASDAQ: TSLA) will increase because they are a direct competitor of Floki Inu."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/25956599/dogecoin-may-not-be-going-to-the-moon-today-but-it-sure-is-helping-the-people-of-ukraine", "title": "Dogecoin May Not Be Going To The Moon Today But It Sure Is Helping The People Of Ukraine", "date": "2022-03-03 06:47", "summary": "Dogecoin (CRYPTO: DOGE) traded 0.4% lower at $0.13 over 24 hours leading up to early Thursday morning.\u00a0", "tickers": ["DOGEUSD", "TSLA"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Dogecoin May Not Be Going To The Moon Today But It Sure Is Helping The People Of Ukraine. Dogecoin (CRYPTO: DOGE) traded 0.4% lower at $0.13 over 24 hours leading up to early Thursday morning.\u00a0\"\n\nStock Prediction(s) for DOGEUSD, TSLA:", "Prediction": "\n- Dogecoin (CRYPTO: DOGE) will increase because it is being used to help people in need, and it is a good cause.\n- Tesla, Inc. (NASDAQ: TSLA) will increase because they are a good company with a good product."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25929318/5-stocks-to-watch-for-march-2-2022", "title": "5 Stocks To Watch For March 2, 2022", "date": "2022-03-03 01:51", "summary": "Some of the stocks that may grab investor focus today are:", "tickers": ["AEO", "ANF", "CRM", "DLTR", "HPE"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"5 Stocks To Watch For March 2, 2022. Some of the stocks that may grab investor focus today are:\"\n\nStock Prediction(s) for AEO, ANF, CRM, DLTR, HPE:", "Prediction": "\n- American Eagle Outfitters, Inc. (NYSE: AEO) will increase because they are expanding their business.\n- Abercrombie & Fitch Co. (NYSE: ANF) will increase because they are expanding their business.\n- Salesforce.com, Inc. (NYSE: CRM) will increase because they are expanding their business.\n- Dollar Tree, Inc. (NASDAQ: DLTR) will increase because they are expanding their business.\n- Hewlett Packard Enterprise Company (NYSE: HPE) will increase because they are expanding their business."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cannabis/22/03/25968152/regrow-offers-single-pane-of-glass-view-to-cannabis-operators-delivered-via-servicenow", "title": "Regrow Offers Single Pane Of Glass View To Cannabis Operators Delivered Via ServiceNow", "date": "2022-03-03 11:48", "summary": "Cannabis-focused supply chain management cloud platform Regrow is integrating with enterprise-level systems to provide powerful workflow and management tools to cannabis operators.", "tickers": ["CRM", "NOW", "SAP", "TWLO", "WDAY"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Regrow Offers Single Pane Of Glass View To Cannabis Operators Delivered Via ServiceNow. Cannabis-focused supply chain management cloud platform Regrow is integrating with enterprise-level systems to provide powerful workflow and management tools to cannabis operators.\"\n\nStock Prediction(s) for CRM, NOW, SAP, TWLO, WDAY:", "Prediction": "\n- Salesforce.com, Inc. (NYSE: CRM) will increase because they offer a single pane of glass view to cannabis operators, and they are a major player in the enterprise-level systems market.\n- ServiceNow Inc (NYSE: NOW) will increase because they offer a single pane of glass view to cannabis operators, and they are a major player in the enterprise-level systems market.\n- SAP SE (NYSE: SAP) will increase because they offer a single pane of glass view to cannabis operators, and they are a major player in the enterprise-level systems market.\n- Twilio Inc ("}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25896231/5-stocks-to-watch-for-march-1-2022", "title": "5 Stocks To Watch For March 1, 2022", "date": "2022-03-03 01:51", "summary": "Some of the stocks that may grab investor focus today are:", "tickers": ["CRM", "DPZ", "GRPN", "HPQ", "TGT"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"5 Stocks To Watch For March 1, 2022. Some of the stocks that may grab investor focus today are:\"\n\nStock Prediction(s) for CRM, DPZ, GRPN, HPQ, TGT:", "Prediction": "\n- Salesforce.com, Inc. (NYSE: CRM) will increase because they are releasing a new product.\n- Domino's Pizza, Inc. (NYSE: DPZ) will increase because they are releasing a new product.\n- Groupon, Inc. (NASDAQ: GRPN) will increase because they are releasing a new product.\n- HP Inc. (NYSE: HPQ) will increase because they are releasing a new product.\n- Target Corporation (NYSE: TGT) will increase because they are releasing a new product."}, {"source": "benzinga", "link": "https://www.benzinga.com/government/22/03/25957302/more-us-companies-join-in-restricting-products-and-services-in-russia", "title": "More US Companies Join In Restricting Products and Services In Russia", "date": "2022-03-03 09:08", "summary": "Russia&#39;s invasion of Ukraine last week, citing a &#34;special operation,&#34; prompted the Western governments to put sanctions on Russia. Many major U.S. conglomerates are aligning with the sanctions and are restricting their products and services in Russia.", "tickers": ["NFLX", "ORCL", "SAP", "SPOT"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"More US Companies Join In Restricting Products and Services In Russia. Russia&#39;s invasion of Ukraine last week, citing a &#34;special operation,&#34; prompted the Western governments to put sanctions on Russia. Many major U.S. conglomerates are aligning with the sanctions and are restricting their products and services in Russia.\"\n\nStock Prediction(s) for NFLX, ORCL, SAP, SPOT:", "Prediction": "\n- Netflix, Inc. (NASDAQ: NFLX) will increase because they are not doing business in Russia, and they are a major player in the streaming industry.\n- Oracle Corporation (NYSE: ORCL) will increase because they are not doing business in Russia, and they are a major player in the software industry.\n- SAP SE (NYSE: SAP) will increase because they are not doing business in Russia, and they are a major player in the software industry.\n- Spotify Technology SA (NYSE: SPOT) will increase because they are not doing business in Russia, and they are a major player in the"}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25967692/pam-tommy-to-pamela-and-netflix-new-doc-to-tell-the-real-story-that-hulu-dramatized", "title": "'Pam & Tommy' To Pamela And Netflix: New Doc To Tell The 'Real' Story That Hulu Dramatized", "date": "2022-03-03 17:19", "summary": "Hulu could have one of its biggest original hits on its hands thanks to the success of \u201cPam &amp; Tommy,&#34; but Netflix Inc (NASDAQ: NFLX)\u00a0could steal some thunder.", "tickers": ["AMZN", "CMCSA", "DIS", "NFLX"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"'Pam & Tommy' To Pamela And Netflix: New Doc To Tell The 'Real' Story That Hulu Dramatized. Hulu could have one of its biggest original hits on its hands thanks to the success of \u201cPam &amp; Tommy,&#34; but Netflix Inc (NASDAQ: NFLX)\u00a0could steal some thunder.\"\n\nStock Prediction(s) for AMZN, CMCSA, DIS, NFLX:", "Prediction": "\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they are now getting into the documentary business.\n- Comcast Corporation (NASDAQ: CMCSA) will increase because they own Hulu, which is where the documentary is being aired.\n- The Walt Disney Company (NYSE: DIS) will increase because they own ESPN, which is airing the documentary.\n- Netflix, Inc. (NASDAQ: NFLX) will increase because they are the exclusive streaming provider for the documentary."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25964208/disney-to-offer-first-dutch-drama-in-effort-to-expand-european-audience", "title": "Disney+ To Offer First Dutch Drama In Effort To Expand European Audience", "date": "2022-03-03 10:58", "summary": "Walt Disney Co\u00a0(NYSE: DIS) has announced the addition of \u201cNemesis\u201d as the first Dutch production for streaming on Disney+.", "tickers": ["AMZN", "DIS", "NFLX"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Disney+ To Offer First Dutch Drama In Effort To Expand European Audience. Walt Disney Co\u00a0(NYSE: DIS) has announced the addition of \u201cNemesis\u201d as the first Dutch production for streaming on Disney+.\"\n\nStock Prediction(s) for AMZN, DIS, NFLX:", "Prediction": "\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they are expanding their European audience.\n- The Walt Disney Company (NYSE: DIS) will increase because they are expanding their European audience.\n- Netflix, Inc. (NASDAQ: NFLX) will decrease because they are losing a competitive edge to Disney+."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25955230/cathie-wood-trims-ark-disney-stake-by-58-on-wednesday", "title": "Cathie Wood Trims Ark Disney Stake By 58% On Wednesday", "date": "2022-03-02 22:44", "summary": "Cathie Wood-led Ark Investment Management on Wednesday significantly lowered its exposure in Walt Disney Co (NYSE: DIS), its second major reduction in the entertainment giant company\u2019s stock since buying the first shares in May last year.", "tickers": ["ARKW", "DIS", "NFLX", "ZM"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Cathie Wood Trims Ark Disney Stake By 58% On Wednesday. Cathie Wood-led Ark Investment Management on Wednesday significantly lowered its exposure in Walt Disney Co (NYSE: DIS), its second major reduction in the entertainment giant company\u2019s stock since buying the first shares in May last year.\"\n\nStock Prediction(s) for ARKW, DIS, NFLX, ZM:", "Prediction": "\n- Ark Worldwide Inc (NYSE: ARKW) will decrease because their main investor is selling off their Disney stock.\n- Walt Disney Co (NYSE: DIS) will decrease because their main investor is selling off their Disney stock.\n- Netflix, Inc. (NASDAQ: NFLX) will increase because they are not associated with Disney.\n- Zoom Video Communications, Inc. (NASDAQ: ZM) will increase because they are not associated with Disney."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/biotech/22/03/25959584/johnson-johnsons-covid-19-vaccine-less-effective-against-hospitalization-french-study-shows", "title": "Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows", "date": "2022-03-03 09:54", "summary": "According to a large French study, the risk of hospitalization after vaccination with\u00a0Johnson &amp; Johnson&#39;s\u00a0(NYSE: JNJ) COVID-19 vaccine was about five times higher than those who received the\u00a0Pfizer Inc\u00a0(NYSE: ", "tickers": ["BNTX", "JNJ", "PFE"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows. According to a large French study, the risk of hospitalization after vaccination with\u00a0Johnson &amp; Johnson&#39;s\u00a0(NYSE: JNJ) COVID-19 vaccine was about five times higher than those who received the\u00a0Pfizer Inc\u00a0(NYSE: \"\n\nStock Prediction(s) for BNTX, JNJ, PFE:", "Prediction": "\n- BioNTech SE (NASDAQ: BNTX) will increase because their vaccine is less effective, but they are still a competitor of Johnson & Johnson.\n- Johnson & Johnson (NYSE: JNJ) will decrease because their vaccine is less effective, and they are a direct competitor of BioNTech.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of BioNTech."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/penny-stocks/22/03/25964390/oneconnect-files-for-hong-kong-listing-but-customer-diversification-remains-key", "title": "OneConnect Files for Hong Kong Listing, But Customer Diversification Remains Key", "date": "2022-03-03 09:47", "summary": "Key Takeaways:", "tickers": ["LU", "OCFT", "XPEV"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"OneConnect Files for Hong Kong Listing, But Customer Diversification Remains Key. Key Takeaways:\"\n\nStock Prediction(s) for LU, OCFT, XPEV:", "Prediction": "\n- OneConnect Financial Technology Ltd. (HKG: 0168) will increase because they are filing for a Hong Kong listing, and they are a direct competitor of XPEV.\n- OneConnect Financial Technology Ltd. (HKG: 0168) will decrease because they are a direct competitor of OCFT.\n- XPEV will increase because they are filing for a Hong Kong listing, and they are a direct competitor of OCFT.\n- OCFT will decrease because they are a direct competitor of XPEV."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/22/03/25969501/what-8-analyst-ratings-have-to-say-about-exxon-mobil", "title": "What 8 Analyst Ratings Have To Say About Exxon Mobil", "date": "2022-03-03 12:05", "summary": "Within the last quarter, Exxon Mobil (NYSE:XOM) has observed the following analyst ratings: ", "tickers": ["XOM"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"What 8 Analyst Ratings Have To Say About Exxon Mobil. Within the last quarter, Exxon Mobil (NYSE:XOM) has observed the following analyst ratings: \"\n\nStock Prediction(s) for XOM:", "Prediction": "\n- Exxon Mobil (NYSE:XOM) will increase because they have a strong outlook and are observing positive analyst ratings.\n- Exxon Mobil (NYSE:XOM) will decrease because they are a direct competitor of Chevron (NYSE:CVX)."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/25964972/why-analyst-calls-exxon-mobil-a-growth-stock", "title": "Is Exxon Mobil Really A Growth Stock Right Now?", "date": "2022-03-03 11:20", "summary": "Exxon Mobil Corp (NYSE: XOM) shares are up 25.4% year-to-date in 2022 as investors have piled into energy stocks, value stocks and dividend stocks. One analyst said Thursday that a closer look at Exxon&#39;s fundamentals reveals it may actually be an under-the-radar growth stock.", "tickers": ["XOM"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Is Exxon Mobil Really A Growth Stock Right Now?. Exxon Mobil Corp (NYSE: XOM) shares are up 25.4% year-to-date in 2022 as investors have piled into energy stocks, value stocks and dividend stocks. One analyst said Thursday that a closer look at Exxon&#39;s fundamentals reveals it may actually be an under-the-radar growth stock.\"\n\nStock Prediction(s) for XOM:", "Prediction": "\n- Exxon Mobil Corp (NYSE: XOM) will continue to increase because they are a growth stock.\n- Other energy stocks will also increase because investors are piling into the sector."}, {"source": "benzinga", "link": "https://www.benzinga.com/22/03/25964297/russian-oil-trade-in-limbo-threatening-global-supply", "title": "Russian Oil Trade In Limbo - Threatening Global Supply", "date": "2022-03-03 09:46", "summary": "Despite efforts by Western countries to spare the energy sector from economic sanctions against Russia, the country\u2019s oil supply has been left hanging in the balance as importers \u2014 including those in the US \u2014 put orders on hold as they seek other sources, potentially threatening the global energy supply.", "tickers": ["BP", "SHEL", "XOM"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Russian Oil Trade In Limbo - Threatening Global Supply. Despite efforts by Western countries to spare the energy sector from economic sanctions against Russia, the country\u2019s oil supply has been left hanging in the balance as importers \u2014 including those in the US \u2014 put orders on hold as they seek other sources, potentially threatening the global energy supply.\"\n\nStock Prediction(s) for BP, SHEL, XOM:", "Prediction": "\n- BP plc (NYSE: BP) will increase because they are a major oil supplier and they have not been sanctioned.\n- Shell Transport and Trading Co. plc (NYSE: SHEL) will increase because they are a major oil supplier and they have not been sanctioned.\n- Exxon Mobil Corporation (NYSE: XOM) will increase because they are a major oil supplier and they have not been sanctioned."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/movers/22/03/25970961/why-amd-asml-holding-nv-and-micron-shares-are-falling-today", "title": "Why AMD, ASML Holding NV And Micron Shares Are Falling Today", "date": "2022-03-03 13:54", "summary": "Shares of several stocks in the broader technology sector, including Advanced Micro Devices, Inc. (NASDAQ: AMD), ASML Holding NV (NASDAQ: ASML) and Micron Technology, Inc. (NASDAQ: ", "tickers": ["AMD", "ASML", "DIA", "MU", "QQQ", "SPY"], "sentiments": [0, 0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why AMD, ASML Holding NV And Micron Shares Are Falling Today. Shares of several stocks in the broader technology sector, including Advanced Micro Devices, Inc. (NASDAQ: AMD), ASML Holding NV (NASDAQ: ASML) and Micron Technology, Inc. (NASDAQ: \"\n\nStock Prediction(s) for AMD, ASML, DIA, MU, QQQ, SPY:", "Prediction": "\n- Advanced Micro Devices, Inc. (NASDAQ: AMD) will decrease because their competitor, Intel, is releasing a new product that will likely take market share.\n- ASML Holding NV (NASDAQ: ASML) will decrease because their competitor, Intel, is releasing a new product that will likely take market share.\n- The Dow Jones Industrial Average (DJIA) will decrease because the technology sector is taking a hit.\n- Micron Technology, Inc. (NASDAQ: MU) will decrease because their competitor, Intel, is releasing a new product that will likely take market share.\n- The Nasdaq"}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/25965165/advanced-micro-devices-whale-trades-for-march-03", "title": "Advanced Micro Devices Whale Trades For March 03", "date": "2022-03-03 10:15", "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Advanced Micro Devices.\nLooking at options history for Advanced Micro Devices (NASDAQ:AMD) we detected 11 strange trades.", "tickers": ["AMD"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Advanced Micro Devices Whale Trades For March 03. A whale with a lot of money to spend has taken a noticeably bearish stance on Advanced Micro Devices.\nLooking at options history for Advanced Micro Devices (NASDAQ:AMD) we detected 11 strange trades.\"\n\nStock Prediction(s) for AMD:", "Prediction": "\n- Advanced Micro Devices (NASDAQ:AMD) will decrease because a whale has taken a bearish stance on the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25961833/heres-why-grab-shares-are-plunging-post-q4-results", "title": "Here's Why Grab Shares Are Plunging Post Q4 Results", "date": "2022-03-03 08:52", "summary": "Grab Holdings Inc\u00a0(NASDAQ: GRAB)\u00a0reported a fourth-quarter", "tickers": ["GRAB"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Here's Why Grab Shares Are Plunging Post Q4 Results. Grab Holdings Inc\u00a0(NASDAQ: GRAB)\u00a0reported a fourth-quarter\"\n\nStock Prediction(s) for GRAB:", "Prediction": "\n- Grab Holdings Inc (NASDAQ: GRAB) will continue to decline because of their poor Q4 results."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/25970513/why-ford-analysts-see-reorganization-as-dawn-of-new-era-expect-other-automakers-to-", "title": "Why Ford Analysts See Reorganization As 'Dawn Of New Era,' Expect Other Automakers To Follow Suit", "date": "2022-03-03 16:19", "summary": "Ford Motor Company (NYSE: F) announced a reorganization plan Wednesday to  separate its internal combustion engine and electric vehicle businesses. ", "tickers": ["F", "GM", "HYMTF", "STLA"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why Ford Analysts See Reorganization As 'Dawn Of New Era,' Expect Other Automakers To Follow Suit. Ford Motor Company (NYSE: F) announced a reorganization plan Wednesday to  separate its internal combustion engine and electric vehicle businesses. \"\n\nStock Prediction(s) for F, GM, HYMTF, STLA:", "Prediction": "\n- Ford Motor Company (NYSE: F) will increase because this is the beginning of a new era for the company, and they are the first to make this move.\n- General Motors Company (NYSE: GM) will decrease because they are a direct competitor of Ford, and they have not announced any similar plans yet.\n- Hyundai Motor Company (KRX: 005380) will increase because this is the beginning of a new era for the company, and they are the first to make this move.\n- Stanley Black & Decker, Inc. (NYSE: SWK) will increase because they are a direct competitor"}, {"source": "benzinga", "link": "https://www.benzinga.com/government/22/03/25956834/elon-musk-issues-challenge-to-uaw-try-and-unionize-tesla-fremont-factory-workers-at-your-convenience", "title": "Elon Musk Issues Challenge To UAW: Try And Unionize Tesla Fremont Factory Workers At Your 'Convenience' And See if You Win", "date": "2022-03-03 06:12", "summary": "Tesla Inc (NASDAQ: TSLA) CEO Elon Musk on Thursday challenged the United Auto Workers (UAW) labor union\u00a0to hold a vote at their &#34;convenience&#34; at the EV maker\u2019s Fremont factory in California and see if they manage to win.", "tickers": ["F", "GM", "TSLA"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Elon Musk Issues Challenge To UAW: Try And Unionize Tesla Fremont Factory Workers At Your 'Convenience' And See if You Win. Tesla Inc (NASDAQ: TSLA) CEO Elon Musk on Thursday challenged the United Auto Workers (UAW) labor union\u00a0to hold a vote at their &#34;convenience&#34; at the EV maker\u2019s Fremont factory in California and see if they manage to win.\"\n\nStock Prediction(s) for F, GM, TSLA:", "Prediction": "\n- Ford Motor Company (NYSE: F) will increase because they are not a direct competitor of Tesla.\n- General Motors Company (NYSE: GM) will decrease because they are a direct competitor of Tesla.\n- Tesla Inc (NASDAQ: TSLA) will increase because they are not a direct competitor of Ford or General Motors."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25956450/rivian-faces-growing-online-backlash-after-increasing-car-prices-thousands-claim-to-cancel-orders", "title": "Rivian Faces Growing Online Backlash After Increasing Car Prices, Thousands Claim To Cancel Orders", "date": "2022-03-03 05:35", "summary": "Rivian Automotive Inc\u00a0(NASDAQ:\u00a0RIVN) is facing an onslaught of peeved customers online, with many claiming to cancel reservations on online forums after the electric vehicle maker announced price hikes.", "tickers": ["AMZN", "F", "RIVN"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Rivian Faces Growing Online Backlash After Increasing Car Prices, Thousands Claim To Cancel Orders. Rivian Automotive Inc\u00a0(NASDAQ:\u00a0RIVN) is facing an onslaught of peeved customers online, with many claiming to cancel reservations on online forums after the electric vehicle maker announced price hikes.\"\n\nStock Prediction(s) for AMZN, F, RIVN:", "Prediction": "\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they are not selling Rivian cars, and they are a competitor of F.\n- Ford Motor Company (NYSE: F) will increase because they are not selling Rivian cars, and they are a competitor of Rivian.\n- Rivian Automotive Inc (NASDAQ: RIVN) will decrease because they are facing backlash for increasing prices, and they are a direct competitor of Ford."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25957009/ford-christens-ev-unit-as-model-e-a-name-elon-musk-was-after-for-tesla-sedan-in-2014", "title": "Ford Christens EV Unit As Model e \u2014 A Name Elon Musk Was After For Tesla Sedan In 2014", "date": "2022-03-03 05:31", "summary": "Ford Motor Co (NYSE: F) on Wednesday revealed plans to use Model e as the name of its electric vehicle unit, eight years after the legacy automaker cut short Tesla Inc\u2019s (NASDAQ: TSLA)", "tickers": ["F", "TSLA"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Ford Christens EV Unit As Model e \u2014 A Name Elon Musk Was After For Tesla Sedan In 2014. Ford Motor Co (NYSE: F) on Wednesday revealed plans to use Model e as the name of its electric vehicle unit, eight years after the legacy automaker cut short Tesla Inc\u2019s (NASDAQ: TSLA)\"\n\nStock Prediction(s) for F, TSLA:", "Prediction": "\n- Ford Motor Co (NYSE: F) will increase because they are now focusing on electric vehicles, and this is a good move for the company.\n- Tesla Inc (NASDAQ: TSLA) will decrease because they are a direct competitor of Ford, and Ford is now focusing on electric vehicles."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25955764/ford-mustang-mach-e-sales-nearly-halve-in-february-mark-bigger-drop-than-gas-powered-version", "title": "Ford Mustang Mach-E Sales Nearly Halve In February, Mark Bigger Drop Than Gas-Powered Version", "date": "2022-03-03 00:27", "summary": "Ford Motor Co\u2019s (NYSE:\u00a0F)\u00a0Mustang\u00a0Mach-E\u00a0sales nearly halved in February, the automaker\u2019s monthly sales data showed on Wednesday, posting a bigger drop than its gasoline counterpart.", "tickers": ["F"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Ford Mustang Mach-E Sales Nearly Halve In February, Mark Bigger Drop Than Gas-Powered Version. Ford Motor Co\u2019s (NYSE:\u00a0F)\u00a0Mustang\u00a0Mach-E\u00a0sales nearly halved in February, the automaker\u2019s monthly sales data showed on Wednesday, posting a bigger drop than its gasoline counterpart.\"\n\nStock Prediction(s) for F:", "Prediction": "\n- Ford Motor Co (NYSE: F) will decrease because their electric Mustang Mach-E sales have not been as successful as they had hoped."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25929110/elon-musk-gains-at-tesla-rival-rivian-as-latter-hikes-prices-their-negative-gross-margin-will-be-sta", "title": "Elon Musk Guns At Tesla Rival Rivian As Latter Hikes Prices: 'Their Negative Gross Margin Will Be Staggering'", "date": "2022-03-02 20:54", "summary": "Tesla Inc (NASDAQ: TSLA) CEO Elon Musk on Tuesday took a dig at smaller electric vehicle rival Rivian Automotive Inc (NASDAQ: RIVN) saying the recently", "tickers": ["AMZN", "F", "LCID", "RIVN", "TSLA"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Elon Musk Guns At Tesla Rival Rivian As Latter Hikes Prices: 'Their Negative Gross Margin Will Be Staggering'. Tesla Inc (NASDAQ: TSLA) CEO Elon Musk on Tuesday took a dig at smaller electric vehicle rival Rivian Automotive Inc (NASDAQ: RIVN) saying the recently\"\n\nStock Prediction(s) for AMZN, F, LCID, RIVN, TSLA:", "Prediction": "\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they are expanding their electric vehicle business.\n- Ford Motor Company (NYSE: F) will increase because they are expanding their electric vehicle business.\n- Lidar Inc (NASDAQ: LCID) will increase because they are a supplier for electric vehicles.\n- Rivian Automotive Inc (NASDAQ: RIVN) will increase because they are expanding their electric vehicle business.\n- Tesla Inc (NASDAQ: TSLA) will increase because they are expanding their electric vehicle business."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/22/03/25972869/analyst-ratings-for-citigroup", "title": "Analyst Ratings For Citigroup", "date": "2022-03-03 14:01", "summary": "Over the past 3 months, 10 analysts have published their opinion on Citigroup (NYSE:C) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company&#39;s business to predict how a stock will trade over the upcoming year.", "tickers": ["C"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Analyst Ratings For Citigroup. Over the past 3 months, 10 analysts have published their opinion on Citigroup (NYSE:C) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company&#39;s business to predict how a stock will trade over the upcoming year.\"\n\nStock Prediction(s) for C:", "Prediction": "\n- Citigroup (NYSE: C) will increase because the majority of analysts have a positive outlook on the stock.\n- Citigroup (NYSE: C) will decrease because there is always a chance that the analysts could be wrong."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/25964482/why-bofa-cuts-citigroup-price-target-after-investor-day", "title": "Why BofA Cuts Citigroup Price Target After Investor Day", "date": "2022-03-03 12:33", "summary": "Citigroup Inc\u2019s (NYSE: C) management presented a \u201crealistic set of financial goals\u201d during the investor day event, according to BofA Securities.", "tickers": ["C"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why BofA Cuts Citigroup Price Target After Investor Day. Citigroup Inc\u2019s (NYSE: C) management presented a \u201crealistic set of financial goals\u201d during the investor day event, according to BofA Securities.\"\n\nStock Prediction(s) for C:", "Prediction": "\n- Citigroup Inc (NYSE: C) will decrease because their financial goals were not as optimistic as investors had hoped."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25970506/hbos-gaming-wall-street-documentary-explores-gamestop-short-squeeze-will-you-watch", "title": "HBO's 'Gaming Wall Street' Documentary Explores GameStop Short Squeeze: Will You Watch?", "date": "2022-03-03 14:21", "summary": "Biltmore Films released Thursday a new documentary featuring GameStop Corp (NYSE: GME) and the retail trading frenzy that surrounded the video game retailer&#39;s stock at the beginning of 2021.", "tickers": ["GME", "HOOD", "T"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"HBO's 'Gaming Wall Street' Documentary Explores GameStop Short Squeeze: Will You Watch?. Biltmore Films released Thursday a new documentary featuring GameStop Corp (NYSE: GME) and the retail trading frenzy that surrounded the video game retailer&#39;s stock at the beginning of 2021.\"\n\nStock Prediction(s) for GME, HOOD, T:", "Prediction": "\n- GameStop Corp (NYSE: GME) will increase because of the documentary that was released, which will bring more attention to the company.\n- HOOD Inc (NASDAQ: HOOD) will increase because they are a direct competitor of GameStop.\n- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) will increase because they are a direct competitor of GameStop."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25957006/cnn-fires-up-streaming-rivalry-bets-350m-on-streaming-service-launch", "title": "CNN Fires Up Streaming Rivalry, Bets $350M On Streaming Service Launch", "date": "2022-03-03 08:36", "summary": "AT&amp;T Inc\u00a0(NYSE: T) WarnerMedia owned Cable news network CNN confirmed launching a news and entertainment streaming service called CNN+ this spring,\u00a0", "tickers": ["DISCA", "FOXA", "T"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"CNN Fires Up Streaming Rivalry, Bets $350M On Streaming Service Launch. AT&amp;T Inc\u00a0(NYSE: T) WarnerMedia owned Cable news network CNN confirmed launching a news and entertainment streaming service called CNN+ this spring,\u00a0\"\n\nStock Prediction(s) for DISCA, FOXA, T:", "Prediction": "\n- Discovery Communications, Inc. (NASDAQ: DISCA) will increase because they are a direct competitor of CNN+ and have been investing in streaming services.\n- Fox Corporation (NASDAQ: FOXA) will increase because they are a direct competitor of CNN+ and have been investing in streaming services.\n- The Walt Disney Company (NYSE: DIS) will decrease because they own CNN+ and have been investing in streaming services."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/technicals/22/03/25966067/chart-wars-cyberwarfare-edition-between-crowdstrike-or-palantir-which-stock-will-go-high", "title": "Chart Wars, Cyberwarfare Edition: Between CrowdStrike Or Palantir, Which Stock Will Go Higher?", "date": "2022-03-03 10:52", "summary": "CrowdStrike Holdings, Inc (NASDAQ: CRWD) and Palantir Technologies, Inc (NYSE: PLTR) shot up on Feb.", "tickers": ["CRWD", "PLTR"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Chart Wars, Cyberwarfare Edition: Between CrowdStrike Or Palantir, Which Stock Will Go Higher?. CrowdStrike Holdings, Inc (NASDAQ: CRWD) and Palantir Technologies, Inc (NYSE: PLTR) shot up on Feb.\"\n\nStock Prediction(s) for CRWD, PLTR:", "Prediction": "\n- CrowdStrike Holdings, Inc (NASDAQ: CRWD) will continue to go up because they are a cybersecurity company and the world is becoming more and more digitized.\n- Palantir Technologies, Inc (NYSE: PLTR) will continue to go up because they are a cybersecurity company and the world is becoming more and more digitized."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/long-ideas/22/03/25975315/us-steel-shares-have-been-on-a-roll-this-week-whats-going-on", "title": "US Steel Shares Have Been On A Roll This Week: What's Going On?", "date": "2022-03-03 17:40", "summary": "United States Steel Corporation\u00a0(NYSE: X) shares are trading higher Thursday after the company announced it will invest approximately $60 million to insource pig iron capabilities at its Gary Works faci", "tickers": ["X"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"US Steel Shares Have Been On A Roll This Week: What's Going On?. United States Steel Corporation\u00a0(NYSE: X) shares are trading higher Thursday after the company announced it will invest approximately $60 million to insource pig iron capabilities at its Gary Works faci\"\n\nStock Prediction(s) for X:", "Prediction": "\n- United States Steel Corporation (NYSE: X) will continue to increase because they are investing money back into their company.\n- Other steel companies will also increase because this will increase the competition and drive down prices."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25964407/looking-into-amc-entertainment-hldgss-return-on-capital-employed", "title": "Looking Into AMC Entertainment Hldgs's Return On Capital Employed", "date": "2022-03-03 09:49", "summary": "According to data from Benzinga Pro, during Q4, AMC Entertainment Hldgs&#39;s (NYSE:AMC) reported sales totaled $1.17 billion. Despite a 40.05% increase in earnings, the company posted a loss of $134.40 million.", "tickers": ["AMC"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Looking Into AMC Entertainment Hldgs's Return On Capital Employed. According to data from Benzinga Pro, during Q4, AMC Entertainment Hldgs&#39;s (NYSE:AMC) reported sales totaled $1.17 billion. Despite a 40.05% increase in earnings, the company posted a loss of $134.40 million.\"\n\nStock Prediction(s) for AMC:", "Prediction": "\n- AMC Entertainment Holdings, Inc. (NYSE: AMC) will decrease because their return on capital employed is negative."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/25955675/amc-shares-updates-on-nfts-accepting-dogecoin-shiba-inu-and-and-launching-own-cryptocurren", "title": "AMC Shares Updates On NFTs, Accepting Dogecoin, Shiba Inu And Launching Own Cryptocurrency", "date": "2022-03-03 03:55", "summary": "AMC Entertainment Holdings Inc.\u00a0(NYSE:\u00a0AMC) CEO\u00a0Adam Aron\u00a0shared updates related to cryptocurrencies,\u00a0citing a \u201cbig opportunity,\u201d on the company&#39;s\u00a0fourth-quarter earnings call on Wednesday.", "tickers": ["AMC", "BTCUSD", "DOGEUSD", "ETHUSD", "SHIBUSD"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"AMC Shares Updates On NFTs, Accepting Dogecoin, Shiba Inu And Launching Own Cryptocurrency. AMC Entertainment Holdings Inc.\u00a0(NYSE:\u00a0AMC) CEO\u00a0Adam Aron\u00a0shared updates related to cryptocurrencies,\u00a0citing a \u201cbig opportunity,\u201d on the company&#39;s\u00a0fourth-quarter earnings call on Wednesday.\"\n\nStock Prediction(s) for AMC, BTCUSD, DOGEUSD, ETHUSD, SHIBUSD:", "Prediction": "\n- AMC Entertainment Holdings Inc. (NYSE: AMC) will increase because they are accepting Dogecoin, Shiba Inu, and launching their own cryptocurrency.\n- BTCUSD will increase because AMC is accepting Dogecoin, and there is a big opportunity for cryptocurrencies.\n- DOGEUSD will increase because AMC is accepting Dogecoin, and there is a big opportunity for cryptocurrencies.\n- ETHUSD will increase because AMC is accepting Dogecoin, and there is a big opportunity for cryptocurrencies.\n- SHIBUSD will increase because AMC is accepting Dogecoin, and there is a big opportunity for cryptocurrencies."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/technicals/22/03/25973617/why-beaten-down-snap-stock-could-be-poised-for-a-reversal", "title": "Why Beaten-Down Snap Stock Could Be Poised For A Reversal", "date": "2022-03-03 15:39", "summary": "Snap, Inc (NYSE: SNAP) was trading down more than 5%\u00a0on Thursday compared to the S&amp;P 500, which was trading near flat after\u00a0a morning dip caused by Federal Reserve chairman Jerome Powell\u2019s testimony in front of the Senate banking committee, where he said the central bank will go ahead with", "tickers": ["SNAP"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why Beaten-Down Snap Stock Could Be Poised For A Reversal. Snap, Inc (NYSE: SNAP) was trading down more than 5%\u00a0on Thursday compared to the S&amp;P 500, which was trading near flat after\u00a0a morning dip caused by Federal Reserve chairman Jerome Powell\u2019s testimony in front of the Senate banking committee, where he said the central bank will go ahead with\"\n\nStock Prediction(s) for SNAP:", "Prediction": "\n- Snap, Inc (NYSE: SNAP) will increase because they have been beaten down recently, but they have a lot of potential and could see a reversal soon.\n- Snap, Inc (NYSE: SNAP) will not increase because they have been beaten down recently, and the market is not expecting a reversal soon."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/25960496/a-treasuredao-vulnerability-made-its-nfts-free-whats-happened-next", "title": "TreasureDAO Vulnerability Made Its NFTs Free: What's Happened Next?", "date": "2022-03-03 13:02", "summary": "A vulnerability in the non-fungible token (NFT) market\u00a0TreasureDAO\u00a0(CRYPTO: MAGIC) purportedly allowed\u00a0attackers to acquire\u00a0NFTs without incurring any cost.", "tickers": ["BTCUSD", "TWTR"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"TreasureDAO Vulnerability Made Its NFTs Free: What's Happened Next?. A vulnerability in the non-fungible token (NFT) market\u00a0TreasureDAO\u00a0(CRYPTO: MAGIC) purportedly allowed\u00a0attackers to acquire\u00a0NFTs without incurring any cost.\"\n\nStock Prediction(s) for BTCUSD, TWTR:", "Prediction": "\n- Bitcoin (BTC) will decrease because of the TreasureDAO vulnerability.\n- Twitter (NYSE: TWTR) will decrease because of the TreasureDAO vulnerability."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/25960479/ukraine-cancels-crypto-airdrop-faces-backlash-from-community", "title": "Ukraine Cancels Crypto Airdrop, Faces Backlash From Community", "date": "2022-03-03 08:11", "summary": "The government of Ukraine has canceled its upcoming cryptocurrency airdrop in what is being described as the first rug-pull by a nation-state.", "tickers": ["BTCUSD", "DOGEUSD", "DOTUSD", "ETHUSD", "TWTR"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Ukraine Cancels Crypto Airdrop, Faces Backlash From Community. The government of Ukraine has canceled its upcoming cryptocurrency airdrop in what is being described as the first rug-pull by a nation-state.\"\n\nStock Prediction(s) for BTCUSD, DOGEUSD, DOTUSD, ETHUSD, TWTR:", "Prediction": "\n- Bitcoin (BTCUSD) will decrease because the airdrop was canceled.\n- Dogecoin (DOGEUSD) will decrease because the airdrop was canceled.\n- Tether (USDT) will decrease because the airdrop was canceled.\n- Ethereum (ETHUSD) will increase because the airdrop was canceled.\n- Twitter (TWTR) will increase because the airdrop was canceled."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25956067/twitter-could-be-charting-into-spotify-apples-territory-by-introducing-podcasts-on-its-platform", "title": "Twitter Could Be Charting Into Spotify, Apple's Territory By Introducing Podcasts On Its Platform", "date": "2022-03-03 02:38", "summary": "Twitter Inc (NASDAQ: TWTR) could be working on a dedicated tab for podcasts, according to a screenshot posted on the microblogging site by security researcher\u00a0Jane Manchun Wong.", "tickers": ["AAPL", "SPOT", "TWTR"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Twitter Could Be Charting Into Spotify, Apple's Territory By Introducing Podcasts On Its Platform. Twitter Inc (NASDAQ: TWTR) could be working on a dedicated tab for podcasts, according to a screenshot posted on the microblogging site by security researcher\u00a0Jane Manchun Wong.\"\n\nStock Prediction(s) for AAPL, SPOT, TWTR:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because they have a lot of money and they could easily buy Twitter.\n- Spotify Technology SA (NYSE: SPOT) will increase because they have been expanding their services and this would be a good addition.\n- Twitter Inc (NYSE: TWTR) will increase because they are introducing podcasts, which is a good way to increase their user base."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25965110/heres-how-much-1000-invested-in-morgan-stanley-10-years-ago-would-be-worth-today", "title": "Here's How Much $1000 Invested In Morgan Stanley 10 Years Ago Would Be Worth Today", "date": "2022-03-03 10:03", "summary": "Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 5.04% on an annualized basis. ", "tickers": ["MS"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Here's How Much $1000 Invested In Morgan Stanley 10 Years Ago Would Be Worth Today. Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 5.04% on an annualized basis. \"\n\nStock Prediction(s) for MS:", "Prediction": "\n- Morgan Stanley (NYSE:MS) will continue to outperform the market because they have been doing well for the past 10 years."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25957757/why-bilibili-shares-are-soaring-today", "title": "Why Bilibili Shares Are Soaring Today", "date": "2022-03-03 07:54", "summary": "Bilibili Inc\u00a0(NASDAQ: BILI)\u00a0reported", "tickers": ["BILI"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why Bilibili Shares Are Soaring Today. Bilibili Inc\u00a0(NASDAQ: BILI)\u00a0reported\"\n\nStock Prediction(s) for BILI:", "Prediction": "\n\n- Bilibili Inc (NASDAQ: BILI) will continue to increase because they are doing well and they have a good future."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25958511/bilibili-q4-earnings-insights", "title": "Bilibili: Q4 Earnings Insights", "date": "2022-03-03 06:55", "summary": "\u00a0\n\nBilibili (NASDAQ:BILI) reported its Q4 earnings results on Thursday, March 3, 2022 at 08:00 AM.\n\nHere&#39;s what investors need to know about the announcement.", "tickers": ["BILI"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Bilibili: Q4 Earnings Insights. \u00a0\n\nBilibili (NASDAQ:BILI) reported its Q4 earnings results on Thursday, March 3, 2022 at 08:00 AM.\n\nHere&#39;s what investors need to know about the announcement.\"\n\nStock Prediction(s) for BILI:", "Prediction": "\n- Bilibili Inc (NASDAQ: BILI) will increase because they had a good Q4 earnings report.\n- Bilibili Inc (NASDAQ: BILI) will decrease because they are a Chinese company and the market is uncertain."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25978989/gap-q4-earnings-highlights-why-shares-are-popping-after-hours", "title": "Gap Q4 Earnings Highlights: Why Shares Are Popping After Hours", "date": "2022-03-03 16:57", "summary": "Gap Inc (NYSE: GPS) reported fourth quarter and full fiscal year results after market close Thursday. Here are the key highlights.", "tickers": ["GPS", "WMT"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Gap Q4 Earnings Highlights: Why Shares Are Popping After Hours. Gap Inc (NYSE: GPS) reported fourth quarter and full fiscal year results after market close Thursday. Here are the key highlights.\"\n\nStock Prediction(s) for GPS, WMT:", "Prediction": "\n- Gap Inc (NYSE: GPS) will increase because their earnings report was good, and they are a major retailer.\n- Wal-Mart Stores, Inc. (NYSE: WMT) will decrease because their earnings report was not as good as Gap Inc, and they are a major retailer."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/long-ideas/22/03/25971237/bulls-just-took-the-upper-hand-in-walmart-stock-heres-why", "title": "Bulls Just Took The Upper Hand In Walmart Stock: Here's Why", "date": "2022-03-03 14:04", "summary": "Walmart Inc. (NYSE: WMT) shares are trading higher Thursday after the company introduced a low price fee on money transfers for its customers to Mexico.", "tickers": ["WMT"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Bulls Just Took The Upper Hand In Walmart Stock: Here's Why. Walmart Inc. (NYSE: WMT) shares are trading higher Thursday after the company introduced a low price fee on money transfers for its customers to Mexico.\"\n\nStock Prediction(s) for WMT:", "Prediction": "\n- Walmart Inc. (NYSE: WMT) will continue to increase because they offer a low price fee on money transfers."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25971298/if-you-invested-100-in-this-stock-5-years-ago-heres-how-much-you-would-have-today", "title": "If You Invested $100 In This Stock 5 Years Ago, Here's How Much You Would Have Today", "date": "2022-03-03 13:02", "summary": "Walmart (NYSE:WMT) has outperformed the market over the past 5 years by 2.03% on an annualized basis. ", "tickers": ["WMT"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"If You Invested $100 In This Stock 5 Years Ago, Here's How Much You Would Have Today. Walmart (NYSE:WMT) has outperformed the market over the past 5 years by 2.03% on an annualized basis. \"\n\nStock Prediction(s) for WMT:", "Prediction": "\n- Walmart (NYSE: WMT) will continue to outperform the market because they have been doing well over the past 5 years."}, {"source": "benzinga", "link": "https://www.benzinga.com/fintech/22/03/25954688/top-news-in-fintech-and-beyond-for-march-3-2022", "title": "Top News In Fintech And Beyond For March 3, 2022", "date": "2022-03-02 20:03", "summary": "\n\n\ud83d\udc49 Top Things To Know In TradeFi \ufe0f", "tickers": ["GS", "SCHW", "WMT"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Top News In Fintech And Beyond For March 3, 2022. \n\n\ud83d\udc49 Top Things To Know In TradeFi \ufe0f\"\n\nStock Prediction(s) for GS, SCHW, WMT:", "Prediction": "\n- Goldman Sachs Group Inc (NYSE: GS) will increase because they are a major player in the fintech space.\n- The Charles Schwab Corporation (NYSE: SCHW) will increase because they are a major player in the fintech space.\n- Wal-Mart Stores, Inc. (NYSE: WMT) will increase because they are a major player in the retail space."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/25968605/moderna-whale-trades-spotted", "title": "Moderna Whale Trades Spotted", "date": "2022-03-03 11:53", "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.\nLooking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.", "tickers": ["MRNA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Moderna Whale Trades Spotted. A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.\nLooking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.\"\n\nStock Prediction(s) for MRNA:", "Prediction": "\n- Moderna Inc (NASDAQ: MRNA) will decrease because a whale has taken a bearish stance on the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/22/03/25962748/expert-ratings-for-teladoc-health", "title": "Expert Ratings For Teladoc Health", "date": "2022-03-03 09:10", "summary": "Within the last quarter, Teladoc Health (NYSE:TDOC) has observed the following analyst ratings: ", "tickers": ["TDOC"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Expert Ratings For Teladoc Health. Within the last quarter, Teladoc Health (NYSE:TDOC) has observed the following analyst ratings: \"\n\nStock Prediction(s) for TDOC:", "Prediction": "\n- Teladoc Health (NYSE:TDOC) will increase because they are a medical company that is expanding and they have good ratings from experts.\n- Teladoc Health (NYSE:TDOC) will decrease because they are a medical company that is expanding and they have good ratings from experts."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25969523/heres-how-much-you-would-have-made-owning-sea-stock-in-the-last-5-years", "title": "Here's How Much You Would Have Made Owning Sea Stock In The Last 5 Years", "date": "2022-03-03 12:03", "summary": "Sea (NYSE:SE) has outperformed the market over the past 5 years by 34.1% on an annualized basis. ", "tickers": ["SE"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Here's How Much You Would Have Made Owning Sea Stock In The Last 5 Years. Sea (NYSE:SE) has outperformed the market over the past 5 years by 34.1% on an annualized basis. \"\n\nStock Prediction(s) for SE:", "Prediction": "\n- Sea will continue to outperform the market because they are a major player in the e-commerce industry.\n- Sea will be a good investment for the long term because they have a strong management team and they are expanding their business rapidly."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/22/03/25967436/analyst-ratings-for-sea", "title": "Analyst Ratings For Sea", "date": "2022-03-03 11:03", "summary": "Analysts have provided the following ratings for Sea (NYSE:SE) within the last quarter: ", "tickers": ["SE"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Analyst Ratings For Sea. Analysts have provided the following ratings for Sea (NYSE:SE) within the last quarter: \"\n\nStock Prediction(s) for SE:", "Prediction": "\n- Sea Ltd (NYSE: SE) will increase because they have received good ratings from analysts.\n- Sea Ltd (NYSE: SE) will decrease because they are a direct competitor of Johnson & Johnson."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/25967415/heres-how-much-1000-invested-in-sea-5-years-ago-would-be-worth-today", "title": "Here's How Much $1000 Invested In Sea 5 Years Ago Would Be Worth Today", "date": "2022-03-03 11:02", "summary": "Sea (NYSE:SE) has outperformed the market over the past 5 years by 34.05% on an annualized basis. ", "tickers": ["SE"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Here's How Much $1000 Invested In Sea 5 Years Ago Would Be Worth Today. Sea (NYSE:SE) has outperformed the market over the past 5 years by 34.05% on an annualized basis. \"\n\nStock Prediction(s) for SE:", "Prediction": "\n- Sea will continue to outperform the market because of their strong track record."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25960845/a-look-into-amazons-debt", "title": "A Look Into Amazon's Debt", "date": "2022-03-03 08:02", "summary": "\u00a0\n\nOver the past three months, shares of Amazon.com (NASDAQ:AMZN) moved lower by nan%. Before having a look at the importance of debt, let us look at how much debt Amazon.com has.", "tickers": ["AMZN"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"A Look Into Amazon's Debt. \u00a0\n\nOver the past three months, shares of Amazon.com (NASDAQ:AMZN) moved lower by nan%. Before having a look at the importance of debt, let us look at how much debt Amazon.com has.\"\n\nStock Prediction(s) for AMZN:", "Prediction": "\n- Amazon.com (NASDAQ:AMZN) will increase because they have been moving lower by nan% and they have a lot of debt.\n- Amazon.com (NASDAQ:AMZN) will not increase because they have been moving lower by nan% and they have a lot of debt."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/25956641/amazon-shuts-68-physical-stores-all-you-need-to-know", "title": "Amazon Shuts 68 Physical Stores: All You Need To Know", "date": "2022-03-03 07:59", "summary": "Amazon.com Inc\u00a0(NASDAQ: AMZN) looks to shut down its Amazon Books physical bookstores, Amazon 4-star and Amazon Pop Up shops,\u00a0", "tickers": ["AMZN"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Amazon Shuts 68 Physical Stores: All You Need To Know. Amazon.com Inc\u00a0(NASDAQ: AMZN) looks to shut down its Amazon Books physical bookstores, Amazon 4-star and Amazon Pop Up shops,\u00a0\"\n\nStock Prediction(s) for AMZN:", "Prediction": "\n- Amazon.com Inc (NASDAQ: AMZN) will decrease because they are shutting down their physical stores."}]